Current Ophthalmology Reports最新文献_第9页

Intracranial Pressure and Its Relationship to Glaucoma 颅内压及其与青光眼的关系

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-05-17 DOI: 10.1007/s40135-021-00267-z

Brandon VanderZee, B. Shafer, John P Berdahl

引用次数: 0

Autologous Blood Products: When, Where, and How? 自体血液制品：何时、何地、如何？

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-03-15 DOI: 10.1007/s40135-021-00266-0

Arianna A. Tovar, Alfonso L. Sabater

引用次数: 2

Update on the Management of Ocular Surface Squamous Neoplasia. 眼表鳞状瘤状病变的治疗进展。

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-03-01 Epub Date: 2021-02-20 DOI: 10.1007/s40135-020-00260-y

Umangi Patel, Carol L Karp, Sander R Dubovy

{"title":"Update on the Management of Ocular Surface Squamous Neoplasia.","authors":"Umangi Patel, Carol L Karp, Sander R Dubovy","doi":"10.1007/s40135-020-00260-y","DOIUrl":"https://doi.org/10.1007/s40135-020-00260-y","url":null,"abstract":"Purpose of review: To review and update the latest findings in diagnosis and management of ocular surface squamous neoplasia (OSSN).Recent findings: OSSN is the most common anterior segment neoplastic disease process. Several ocular surface imaging techniques have been developed for the early diagnosis and management of clinical and subclinical ocular surface squamous neoplasia, including high-resolution optical coherence tomography (HR-OCT), in vivo confocal microscopy, and ultrasound biomicroscopy. Treatment modalities include both surgical and medical management, with a recent trend towards primary and adjunctive pharmacotherapy.Summary: There is increasing use of HR-OCT for the diagnosis and monitoring of clinical and subclinical OSSN lesions. Topical pharmacotherapy agents, including interferon α-2b, 5-fluorouracil, and mitomycin C, have demonstrable efficacy in the treatment of OSSN and their use may be dictated based upon tumor factors, patient factors, cost, and side effect profile. Both surgical excision and adjunctive topical medications have excellent success, with the favored treatment method trending towards topical pharmacotherapy as primary therapy.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"9 1","pages":"7-15"},"PeriodicalIF":0.9,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40135-020-00260-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39643657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

Uveal Melanoma: A Review of Prognostic Factors for Metastases 葡萄膜黑色素瘤:转移的预后因素综述

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-25 DOI: 10.1007/s40135-020-00261-x

Emily Chang, H. Demirci

引用次数: 1

Clinical Studies of COMET for Total LSCD: a Review of the Methods and Molecular Markers for Follow-Up Characterizations COMET治疗完全性LSCD的临床研究:随访表征的方法和分子标志物综述

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-22 DOI: 10.1007/s40135-020-00263-9

E. Attico, G. Galaverni, G. Pellegrini

引用次数: 6

Malignant Orbital Tumors: Current Approach to Diagnosis and Management 眼眶恶性肿瘤：目前的诊断和治疗方法

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-12 DOI: 10.1007/s40135-020-00262-w

Jane S. Kim, Amal Al-lozi, Ilya M. Leyngold

引用次数: 1

Impact of the COVID-19 Pandemic on Refractive Surgery. COVID-19大流行对屈光手术的影响。

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-01 Epub Date: 2021-10-22 DOI: 10.1007/s40135-021-00280-2

Matthew Bickford, Karolinne Rocha

引用次数: 2

Update on Retinal Drug Toxicities. 视网膜药物毒性的最新进展。

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-01 Epub Date: 2021-12-21 DOI: 10.1007/s40135-021-00277-x

S Tammy Hsu, Arathi Ponugoti, Jordan D Deaner, Lejla Vajzovic

{"title":"Update on Retinal Drug Toxicities.","authors":"S Tammy Hsu, Arathi Ponugoti, Jordan D Deaner, Lejla Vajzovic","doi":"10.1007/s40135-021-00277-x","DOIUrl":"https://doi.org/10.1007/s40135-021-00277-x","url":null,"abstract":"Purpose of review: This review aims to provide an update on the clinical presentations and diagnostic findings of drug-induced retinal toxicities.Recent findings: Several newly FDA-approved medications have been associated with acute retinal toxicities, including brolucizumab, MEK inhibitors, ulixertinib, and FGFR inhibitors. Additionally, as previously believed-to-be well-tolerated medications, such as pentosan sulfate sodium, anti-retroviral therapies, and certain intraoperative ocular medications, are used more frequently or for longer periods of time, associated toxic retinopathies and inflammatory reactions have been reported. Finally, advances in ocular imaging have revealed novel findings in hydroxychloroquine and tamoxifen maculopathies.Summary: Discovery of new medications, increased frequency of use, and longer-term use have led to increased reports of retinal toxicities. Advances in retinal imaging have allowed for earlier detection of subclinical changes associated with these medications, which may help prevent progression of disease. However, more research is needed to determine the point at which vision loss becomes irreversible. Risks and benefits must be assessed prior to discontinuation of the offending, but potentially lifesaving, therapy.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"9 4","pages":"168-177"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39764723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

Impact of SARS-CoV-2 on Ocular Surface Pathology and Treatment Practices: a Review. SARS-CoV-2对眼表病理及治疗实践的影响

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-01 Epub Date: 2021-08-05 DOI: 10.1007/s40135-021-00271-3

Sila Bal, James Chodosh, Nandini Venkateswaran

{"title":"Impact of SARS-CoV-2 on Ocular Surface Pathology and Treatment Practices: a Review.","authors":"Sila Bal, James Chodosh, Nandini Venkateswaran","doi":"10.1007/s40135-021-00271-3","DOIUrl":"https://doi.org/10.1007/s40135-021-00271-3","url":null,"abstract":"Purpose of review: The ocular surface is a potential site of ocular involvement by SARS-CoV-2 infection. We performed a review of the literature to understand the pathogenesis of SARS-CoV-2 disease manifestations on the ocular surface as well as to elucidate emerging treatment patterns and practice changes during the COVID-19 pandemic.Recent findings: The ocular manifestations of SARS-CoV-2 are likely limited to a mild and transient conjunctivitis. Other manifestations have not been validated in larger cohorts. Ocular surface tissue should be considered potentially infectious due to the presence of host receptors on surface tissues. The availability of donor tissue in lower-middle income countries has been greatly impacted by the pandemic and would benefit from further investigation into transmissibility through donor tissue.Summary: Transmission of SARS-CoV-2 through the ocular surface has yet to be confirmed. The most common ocular manifestation is a mild conjunctivitis. Ocular surface surgeons face specific challenges in the use of donor tissues and aerosolizing procedures and have adapted practice patterns accordingly.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"9 3","pages":"77-82"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40135-021-00271-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39299924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

The Future Is Now: Incorporating Telemedicine into Glaucoma Care. 未来就是现在:将远程医疗纳入青光眼护理。

IF 0.9

Current Ophthalmology Reports Pub Date : 2021-01-01 Epub Date: 2021-07-07 DOI: 10.1007/s40135-021-00269-x

Monica K Ertel, Malik Y Kahook, Cara E Capitena Young

{"title":"The Future Is Now: Incorporating Telemedicine into Glaucoma Care.","authors":"Monica K Ertel, Malik Y Kahook, Cara E Capitena Young","doi":"10.1007/s40135-021-00269-x","DOIUrl":"https://doi.org/10.1007/s40135-021-00269-x","url":null,"abstract":"Purpose of review: The field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice.Recent findings: Teleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction.Summary: Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"9 3","pages":"88-95"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40135-021-00269-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39178173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4